TANG CAPITAL MANAGEMENT LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 128 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
TANG CAPITAL MANAGEMENT LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2020$12,573,000
-11.7%
1,246,121
-8.7%
2.28%
+64.4%
Q2 2020$14,241,000
+110.9%
1,365,376
+70.7%
1.38%
+46.0%
Q1 2020$6,752,000
+120.9%
800,000
+129.0%
0.95%
+159.7%
Q4 2019$3,057,000
-18.7%
349,4000.0%0.36%
-43.2%
Q3 2019$3,761,000
-15.3%
349,4000.0%0.64%
+7.2%
Q2 2019$4,441,000
-67.2%
349,4000.0%0.60%
-76.0%
Q1 2019$13,553,000
+169.2%
349,400
+41.2%
2.50%
+116.2%
Q4 2018$5,035,000247,4001.16%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders